549
Participants
Start Date
December 18, 2017
Primary Completion Date
February 19, 2024
Study Completion Date
December 31, 2025
Oral paclitaxel
Oral administration on D1, D8 and D15 of 4-week cycle until progression, unacceptable toxicity or withdrawal of informed concent
Paclitaxel injection
Premedication, intravenous infusion on D1, D8 and D15 of 4-week cycle until progression, unacceptable toxicity or withdrawal of informed concent
"Medical Center Nadezhda Clinical Ltd.,", Sofia
Szent Borbála Hospital, Tatabánya
Multi-profile Hospital for Active Treatment Uni Hospital Ltd. Medical Oncology Department, Panagyurishte
Tolna County Balassa János Hospital, Szekszárd
Oncology Complex Center - Burgas'' Ltd., Medical Oncology Department, Burgas
National Cancer Center, Goyang-si
Institute for Oncology and Radiology of Serbia, Belgrade
Clinical Hospital Center Bežanijska Kosa, Department of Oncology, Belgrade
Cha University Cha Bundang Medical Center, Seongnam-si
Ajou University Hospital, Suwon
Clinical Center Niš, Clinic for Oncology, Niš
Health Center Kladovo, Oncology Department, Kladovo
Oncology Institute of Vojvodina, Kamenitz
Chungbuk National University Hospital, Cheongju-si
Clinical Center Kragujevac Center of Oncology and Radiotherapy, Kragujevac
Konyang University Hospital, Daejeon
General Hospital Krusevac, Outpatient Clinic for chemotherapy, Kruševac
Anhui Cancer Hospital, Hefei
Cancer Hospital Chinese Academy Of Medical Sciences, Beijing
Sun Yat-sen University Cancer Center, Guangzhou
The First Affiliated Hospital Of Hainan Medical College, Haikou
Harbin Medical University Cancer Hospital, Harbin
Tianjin Cancer Hospital, Zhengzhou
Jiangsu Cancer Hospital, Nanjing
Jiangsu Province Hospital, Nanjing
First Affiliated Hospital of Jilin University, Changchun
Liaoning Cancer Hospital, Shenyang
Shangdong Cancer Hospital, Jinan
Linyi Cancer Hospital, Linyi
Fudan University Shanghai Cancer Center, Shanghai
The First Affiliated Hospital of Xi'an Jiaotong university, Xi’an
West China School Of Medicine Sichuan University, Chengdu
Zhejiang Cancer Hospital, Hangzhou
Zhejiang University School Of Medicine Sir Run Run Shaw Hospital, Hangzhou
Henan Cancer Hospital, Zhengzhou
Kosin University Gospel Hospital, Busan
Pusan National University Yangsan Hospital, Busan
Keimyung University Dongsan Medical Center, Daegu
Gang Neung Asan Hospital, Gangneung
Gachon University Gil Medical Center, Incheon
Catholic University of Korea Seoul ST. Mary's Hospital, Seoul
Gangnam Severance Hospital, Seoul
Uijeongbu ST. Mary's Hospital, Uijeongbu-si
Wonju Severance Christian Hospital, Wŏnju
Inje University Haeundae Paik Hospital, Busan
Korea University Anam Hospital, Seoul
Seoul National University Hospital, Seoul
Yonsei University Severance Hospital, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Korea University Guro Hospital, Seoul
Lead Sponsor
Daehwa Pharmaceutical Co., Ltd.
INDUSTRY